HIVE vs. QS

Last updated Jun 9, 2026

HIVE (HIVE Blockchain Technologies Ltd) and QS (QuantumScape Corporation) are both stocks. HIVE operates in Capital Markets (Financial Services), while QS operates in Auto Parts (Consumer Cyclical). Over the past 5 years, HIVE returned -20.28%/yr vs -24.41%/yr for QS. At a 0.46 correlation, their price movements are largely independent.

Performance

HIVE vs. QS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HIVE Blockchain Technologies Ltd (HIVE) and QuantumScape Corporation (QS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HIVE achieves a 53.49% return, which is significantly higher than QS's -26.49% return.

HIVE

• 1D: 5.04%
• 1M: 40.43%
• YTD: 53.49%
• 6M: 27.74%
• 1Y: 97.01%
• 3Y*: 9.70%
• 5Y*: -20.28%
• 10Y*: —

QS

• 1D: -0.13%
• 1M: 1.59%
• YTD: -26.49%
• 6M: -39.21%
• 1Y: 85.47%
• 3Y*: 6.73%
• 5Y*: -24.41%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HIVE vs. QS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
HIVE HIVE Blockchain Technologies Ltd	53.49%	-9.47%	-37.09%	214.58%	-89.09%	39.68%	384.86%
QS QuantumScape Corporation	-26.49%	100.77%	-25.32%	22.57%	-74.45%	-73.72%	757.36%

Correlation

The correlation between HIVE and QS is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.43
Correlation (3Y) Calculated over the trailing 3-year period	0.44
Correlation (5Y) Calculated over the trailing 5-year period	0.50
Correlation (All Time) Calculated using the full available price history since Aug 17, 2020	0.46

The correlation between HIVE and QS has been stable across timeframes, ranging from 0.43 to 0.50 - a consistent structural relationship.

Fundamentals

EPS HIVE : -$0.33 QS : -$0.72
Total Revenue (TTM) HIVE : $257.14M QS : $0.00
Gross Profit (TTM) HIVE : $58.57M QS : -$49.03M
EBITDA (TTM) HIVE : $87.81M QS : -$378.92M

Return for Risk

HIVE vs. QS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIVE

HIVE Risk / Return Rank: 70
HIVE Sharpe Ratio Rank: 73
HIVE Sortino Ratio Rank: 76
HIVE Omega Ratio Rank: 72
HIVE Calmar Ratio Rank: 67
HIVE Martin Ratio Rank: 62

QS

QS Risk / Return Rank: 69
QS Sharpe Ratio Rank: 69
QS Sortino Ratio Rank: 75
QS Omega Ratio Rank: 71
QS Calmar Ratio Rank: 67
QS Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIVE vs. QS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for HIVE Blockchain Technologies Ltd (HIVE) and QuantumScape Corporation (QS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HIVE	QS	Difference
Sharpe ratio: Return per unit of total volatility	1.03	0.83	+0.20
Sortino ratio: Return per unit of downside risk	1.97	1.93	+0.04
Omega ratio: Gain probability vs. loss probability	1.23	1.23	+0.01
Calmar ratio: Return relative to maximum drawdown	1.30	1.27	+0.03
Martin ratio: Return relative to average drawdown	2.10	2.00	+0.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HIVE vs. QS - Sharpe Ratio Comparison

The current HIVE Sharpe Ratio is 1.03, which is comparable to the QS Sharpe Ratio of 0.83. The chart below compares the historical Sharpe Ratios of HIVE and QS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HIVE	QS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.03	0.83	+0.20
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.22	-0.29	+0.07
Sharpe Ratio (All Time) Calculated using the full available price history	-0.12	-0.04	-0.08

Drawdowns

HIVE vs. QS - Drawdown Comparison

The maximum HIVE drawdown since its inception was -97.73%, roughly equal to the maximum QS drawdown of -97.36%. Use the drawdown chart below to compare losses from any high point for HIVE and QS.

Drawdown Indicators

	HIVE	QS	Difference
Max Drawdown Largest peak-to-trough decline	-97.73%	-97.36%	-0.37%
Max Drawdown (1Y) Largest decline over 1 year	-74.86%	-67.68%	-7.18%
Max Drawdown (3Y) Largest decline over 3 years	-80.27%	-73.93%	-6.34%
Max Drawdown (5Y) Largest decline over 5 years	-94.61%	-91.45%	-3.16%
Current Drawdown Current decline from peak	-85.24%	-94.18%	+8.94%
Average Drawdown Average peak-to-trough decline	-78.59%	-85.55%	+6.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	46.35%	42.96%	+3.39%

Volatility

HIVE vs. QS - Volatility Comparison

HIVE Blockchain Technologies Ltd (HIVE) has a higher volatility of 39.11% compared to QuantumScape Corporation (QS) at 26.40%. This indicates that HIVE's price experiences larger fluctuations and is considered to be riskier than QS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HIVE	QS	Difference
Volatility (1M) Calculated over the trailing 1-month period	39.11%	26.40%	+12.71%
Volatility (6M) Calculated over the trailing 6-month period	66.45%	48.57%	+17.88%
Volatility (1Y) Calculated over the trailing 1-year period	95.15%	103.45%	-8.30%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	93.06%	85.88%	+7.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	109.22%	106.01%	+3.21%

Dividends

HIVE vs. QS - Dividend Comparison

Neither HIVE nor QS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both HIVE and QS in my portfolio?

HIVE and QS have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HIVE or QS?

HIVE has higher volatility (39.11%) compared to QS (26.40%). In terms of maximum drawdown, HIVE dropped -97.73% vs QS's -97.36%.

Which has better risk-adjusted returns?

HIVE currently has the higher Sharpe Ratio (1.03 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.